African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense. 
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.

Market Analysis and Insights: Global African Trypanosomiasis Market
The global African Trypanosomiasis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global African Trypanosomiasis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global African Trypanosomiasis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global African Trypanosomiasis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global African Trypanosomiasis market.

Global African Trypanosomiasis Scope and Market Size
African Trypanosomiasis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global African Trypanosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense

Segment by Application
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals